You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Concise report
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability

Authors

  1. Correspondence to Dr Jörg HW Distler, Department of Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Ulmenweg 18, Erlangen D-91054, Germany; Joerg.distler{at}uk-erlangen.de
View Full Text

Citation

Distler A, Lang V, Del Vecchio T, et al
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Annals of the Rheumatic Diseases 2014;73:1264-1268.

Publication history

  • Received July 3, 2013
  • Revised December 27, 2013
  • Accepted January 2, 2014
  • First published January 20, 2014.
Online issue publication 
April 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions